Alpha Tau Medical develops Alpha DaRT, a localized radiation therapy technology for solid tumors. DRTS reports earnings on Thu, Nov 19, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 20 | HC Wainwright & Co. | Reiterated | Buy | |
| Sep 3 | Barclays | Target raised | Buy | |
| Aug 11 | HC Wainwright & Co. | Target raised | Buy | |
| Jul 16 | HC Wainwright & Co. | Reiterated | Buy | |
| Jun 4 | Barclays | Target raised | Buy |
Seasonality
How DRTS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
Whale Options Flow
90DNo whale options trades in DRTS in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DRTS is in one of them and how their past DRTS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered DRTS in an article yet. Here's the latest on the wider market.
About Alpha Tau Medical
Alpha Tau Medical is based in Jerusalem, Israel, and develops Alpha DaRT, a localized radiation therapy technology for solid tumors. It uses alpha particles, which travel only short distances, to treat tumors in place. The company is running clinical trials for skin, head and neck, pancreatic and brain tumors, including cancers that are hard to remove surgically or not well served by standard care. Its intended customers are cancer patients and the hospitals and medical centers that treat them.
- Headquarters
- Jerusalem, Israel